L’Initiative L’Initiative
  • L'Initiative
  • Our priorities

      Our priorities

    • HIV/AIDS
    • Tuberculosis
    • Malaria
    • HPV and cervical cancer
    • Gender and human rights
    • Community health
    • Operational Research and Science
    • Human resources for health
  • How we work

      How we work

    • Catalytic project funding
      • Is your project eligible for support?
      • Apply for a call for proposals
      • Explore the projects we support
    • Mobilizing technical expertise
      • Request technical assistance
      • Experts, join us!
    • Addressing overlooked challenges
    • Strengthening civil society capacities
    • Supporting operational research and innovation
    • Learning and improving through evaluation and knowledge-sharing
  • News
  • Resources
    • fr
    • en
  • fr
  • en
  • L'Initiative
  • Our priorities
    • HIV/AIDS
    • Tuberculosis
    • Malaria
    • HPV and cervical cancer
    • Gender and human rights
    • Community health
    • Operational Research and Science
    • Human resources for health
  • How we work
    • Catalytic project funding
      • Is your project eligible for support?
      • Apply for a call for proposals
      • Explore the projects we support
    • Mobilizing technical expertise
      • Request technical assistance
      • Experts, join us!
    • Addressing overlooked challenges
    • Strengthening civil society capacities
    • Supporting operational research and innovation
    • Learning and improving through evaluation and knowledge-sharing
  • News
  • Resources
Recherche
Home > Resources > Policy brief – The malaria vaccine: promising progress, but not a silver bullet
En The Malaria Vaccine Promising Progress But Not A Silver Bullet

Policy brief – The malaria vaccine: promising progress, but not a silver bullet

11 November 2021

Following the WHO announcement recommending a vaccine for children at risk of contracting malaria, this L’Initiative policy brief provides analysis and insight into understanding this first ever malaria vaccine (known as RTS,S).

Malaria

Documents to download

Policy brief - The malaria vaccine promising progress but not a silver bullet (0.55 Mo)

Read also

Editorial Piece
29 · 07 · 2022 HIV/AIDS Malaria +1
Ten years of responding to field needs
Actualité Read the article
Ten years of responding to field needs
Annual Report
20 · 06 · 2024 Cross-cutting HIV/AIDS +2
2023 Activity Report – A decisive step in the response to pandemics
Actualité Read the article
2023 Activity Report – A decisive step in the response to pandemics
Annual Report
12 · 07 · 2023 Cross-cutting HIV/AIDS +2
2022 Activity Report – Redoubling efforts to better combat pandemics
Actualité Read the article
2022 Activity Report – Redoubling efforts to better combat pandemics
Medical injection kit preparation with safety syringes and cotton swabs. Focus
16 · 04 · 2026 Malaria
Malaria: When Operational Research Turns Trials into Solutions
Actualité Read the article
Malaria: When Operational Research Turns Trials into Solutions
Interview
22 · 04 · 2024 HIV/AIDS Malaria
Community preventive strategies to combat malaria
Actualité Read the article
Community preventive strategies to combat malaria
Interview
20 · 06 · 2024 HIV/AIDS Malaria +1
“The Initiative, a tool at the service of populations”
Actualité Read the article
“The Initiative, a tool at the service of populations”
Focus
25 · 04 · 2023 HIV/AIDS Malaria
L’Initiative and operational research on malaria
Actualité Read the article
L’Initiative and operational research on malaria
Focus
24 · 04 · 2021 HIV/AIDS Malaria
Fighting malaria in remote areas: the example of Cambodia
Actualité Read the article
Fighting malaria in remote areas: the example of Cambodia
Impact Of Sunlight Exposure On The Residual Efficacy Of
01 · 01 · 2019
Impact of sunlight exposure on the residual efficacy of biolarvicides Bacillus thuringiensis israelensis and Bacillus sphaericus against the main malaria vector, Anopheles gambiae
Read the article
Impact of sunlight exposure on the residual efficacy of biolarvicides Bacillus thuringiensis israelensis and Bacillus sphaericus against the main malaria vector, Anopheles gambiae
Strategy
19 · 06 · 2025 Cross-cutting HIV/AIDS +3
Staying the course, strengthening the response to pandemics
Actualité Read the article
Staying the course, strengthening the response to pandemics
Back to the list

La Nouvelle Initiative

Sign up to receive our newsletter

Subscribe to our newsletter

I have taken note of the Terms and conditions of use

Implemented by:

Funded and placed under the supervision of:

As part of the French contribution to:

Quick access
How to request technical assistance ? Our calls for proposals Our documentary resources Experts, join us! Legal notice Privacy policy
Contact

Expertise France – L’Initiative
40, boulevard de Port-Royal
75005 Paris, France

Follow us
X
Our news Flux RSS
©Expertise France – 2026
Ce site est protégé par le reCAPTCHA Google.
Politique de confidentialité et conditions d’utilisations.
Agence Ecommerce Rennes

Outils d'accessibilité

  • Taille du texte :
  • Haut contraste
  • Liens soulignés
  • Police lisible
  • Police dyslexique